Mr. Zayed Bin Aweidha, Managing Director, World Investments P.S.C hosted the Canada based Resverlogix strategic team led by Mr. Donald J. McCaffrey, President and CEO, Resverlogix, at the World Investments P.S.C head office in Dubai, UAE.

The high level meeting was a potential joint venture association including setting up an international multi-million dollar fund for Resverlogix’s revolutionary biotech product, APABETALONE, which has demonstrated cardio-protective benefits in high risk Cardiovascular, Diabetic and Kidney patients, utilizing advanced epigenetics to turn multiple disease associated genes on or off. APABETALONE is also known to possess a dual anti-viral and anti-inflammatory gene silencing approach that has extremely high potential with regards to being a significant COVID-19 therapeutic.